Stemline Therapeutics
Show contact
Links
Previous companies
Ivan Bergstein
CEO
Franz Lechner
VP General Manager DACH
Ken Hoberman
Chief Operating Officer
Robert Jerez
Vice President, Quality Systems
Jessica Gache
Executive Assistant to SVP, Global Regulatory Affairs, Drug Safety, Pharmacovigilance & R&D QA
+ 13 more
October, 2019 - present
View in org chart